Andy Riley
Senior Medical Advisor @Eisai EMEA
Signup · Get unlimited contacts
WORK HISTORY
Senior Medical Advisor @Eisai EMEA
I lead above‑country medical affairs across non‑affiliate markets in EMEA, strengthening medical governance, scientific impact, and partner capabilities across oncology, insomnia, and neurodegenerative conditions.Medical Governance & Strategic Leadership- Provide EMEA‑level medical review of scientific and promotional materials under ABPI/EFPIA and regional codes- Oversee managed access requests end‑to‑end, ensuring compliant, timely decision‑making through the Managed Access Committee- Review partner medical strategies and business plans, ensuring alignment with regional needs and global priorities- Support launch and lifecycle activities across multiple therapy areas, adapting evidence and messaging to diverse markets.Medical Excellence & Capability Building- Create high‑impact medical materials tailored to local scientific, clinical, and HCP needs- Developed a new EMEA‑wide MSL training programme, improving consistency and scientific depth across medical teams- Lead comprehensive medical training sessions cross-portfolio- Organised regional medical education events across the Middle East, ensuring high‑quality scientific exchange and HCP engagement.Scientific Engagement & Evidence Generation- Drive KOL strategy, advisory board planning, and engagement activities across key markets- Support local RWE and evidence‑generation projects in Middle Eastern markets, addressing regional data gaps and practice needs- Integrate field insights into regional strategy and cross‑functional planning.Access, Regulatory & Cross‑Functional Collaboration- Partner with Market Access and Regulatory Affairs to shape dossiers, clinical summaries, and appeals for FDA‑/EMA‑aligned authorities- Ensure medical input strengthens access narratives and supports payer decision‑making across diverse systems.
EDUCATION
University of Hull
Bachelor of Science (BSc), Biomedical science
SKILLS
ABOUT ANDY RILEY
As a Senior Medical Advisor supporting non‑affiliate partner markets across EMEA, I accelerate access and medical excellence across diverse healthcare systems in the Middle East and Europe. With strong experience in oncology, insomnia and Alzheimer’s disease, I provide EMEA‑level medical review of scientific and promotional materials in accordance with ABPI/EFPIA and local frameworks, ensuring high standards of accuracy and medical governance. My work also focuses on strengthening medical excellence across partner markets; reviewing medical business plans, supporting advisory boards, enabling robust KOL engagement, training MSLs, and guiding local evidence generation and RWE initiatives. I work cross‑functionally to equip partners with the tools, governance, and scientific resources required for confident and compliant execution. In parallel, I collaborate with Regulatory and Market Access teams to craft dossiers, clinical summaries and appeals for FDA‑ and EMA-aligned, regional health authorities. Partnering closely with commercial leadership, I align medical strategy with portfolio priorities and ensure scientific support for key launches and in‑market brands.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.